South Korea Designates 5 New Drugs, Including Synthetic Marijuana and LSD

Innovation by 2FIRSTS.ai
Dec.13.2023
South Korea Designates 5 New Drugs, Including Synthetic Marijuana and LSD
South Korea designates 5 new substances, including synthetic cannabis and LSD, as new drugs; customs intercept 35 related cases.

According to a report by KIHOILBO, South Korea has officially identified and classified four synthetic marijuana series and one LSD series, totaling five substances, as new types of drugs.

 

Customs at Incheon International Airport have successfully intercepted five new types of domestically imported drugs in the past two years that have altered the existing chemical structure of illicit substances and possess similar effects but are not regulated by law. In June of this year, customs authorities confirmed through meticulous analysis that e-cigarette liquid smuggled into the country from Vietnam contained 'MDMB-INACA,' a compound resembling synthetic marijuana.

 

In the following two years, customs authorities have discovered four types of synthetic marijuana series with hallucinogenic effects and high addictive potential ('MDMB-INACA', 'ADB-INACA', '5C-MDA-19', 'ADB-FUBIATA'), as well as one type of LSD series ('1V-LSD') which is known to cause severe physical and psychological dependence after misuse.

 

Customs has submitted a request to the South Korean Food and Drug Safety Agency to designate these new types of drugs as controlled substances. Recently, the Food and Drug Safety Agency has officially designated these substances as new types of drugs.

 

After the designation of these new drugs, Incheon Airport Customs has successfully identified 35 cases of crimes related to the new drugs, including 17 cases of the new drug 'ADB-FUBIATA,' 13 cases of 'MDMB-INACA,' 3 cases of 'ADB-INACA,' 1 case of '1V-LSD,' and 1 case of '5C-MDA-19'.

 

Customs officials at Incheon Airport stated that they will collaborate closely with relevant departments to prevent the domestic entry of drugs, ensuring social security and safeguarding public health. Customs will also take the strictest measures to combat criminal activities involving new types of drugs.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Virginia asks Fourth Circuit to stay order blocking parts of its unauthorized-vape sales law
Virginia asks Fourth Circuit to stay order blocking parts of its unauthorized-vape sales law
Virginia has asked the U.S. Court of Appeals for the Fourth Circuit to stay a district court order that blocks enforcement of certain provisions of a state law restricting the sale of unauthorized vaping products. The district court held the law was preempted to the extent it enforced federal requirements under the FDCA and the Tobacco Control Act.
Jan.21 by 2FIRSTS.ai
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Mar.12
South Korea Postal Service Launches Heated Tobacco Device Recycling Program Through Nationwide Post Offices and Mailboxes
South Korea Postal Service Launches Heated Tobacco Device Recycling Program Through Nationwide Post Offices and Mailboxes
Korean postal system launches nationwide heated tobacco device recycling through post offices and mailboxes, aiming to increase recycling rates.
Feb.10 by 2FIRSTS.ai
RJ Reynolds asks ITC to investigate alleged vape restriction violations by Heaven Gifts network
RJ Reynolds asks ITC to investigate alleged vape restriction violations by Heaven Gifts network
R.J. Reynolds Tobacco Co. has asked the U.S. International Trade Commission to open a Section 337 investigation into Heaven Gifts International — the umbrella company behind Elf Bars and Geek Bars — its subsidiaries and nine U.S. distributors.
Jan.16 by 2FIRSTS.ai
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
British American Tobacco said 2026 will mark a return to its mid-term growth algorithm, but CEO Tadeu Marroco stressed that deliverywill depend heavily on enforcement against illicit vapour products in the United States. Speaking at the FY2025 results call, he positioned Modern Oral as the company’s primary structural growth engine, reframed accelerating cigarette declines through “poly-usage,” and reinforced capital discipline with an expanded share buyback plan.
Feb.12
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11